Early Work on the Ubiquitin Proteasome System, an Interview with Avram Hershko
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Springer A++ Viewer
PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central Ubiquitin researchers win Nobel ArticleInfo ArticleID : 5007 ArticleDOI : 10.1186/gb-spotlight-20041007-02 ArticleCitationID : spotlight-20041007-02 ArticleSequenceNumber : 70 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 3 RegistrationDate : 2004–10–7 ArticleHistory : OnlineDate : 2004–10–7 ArticleCopyright : BioMed Central Ltd2004 ArticleGrants : ArticleContext : 130595511 Stephen Pincock Email: [email protected] Three researchers who made fundamental breakthroughs in understanding ubiquitin-mediated proteolysis have been awarded the 2004 Nobel Prize in Chemistry, the Royal Swedish Academy of Sciences said on Wednesday (October 6). Aaron Ciechanover and Avram Hershko, from the Israel Institute of Technology, Haifa, and Irwin Rose, of the University of California, Irvine, will share the prize for their discoveries in the 1970s and 1980s that began to reveal the central role of the tiny 76-amino acid protein in numerous cellular processes. "Thanks to the work of the three laureates, it is now possible to understand at a molecular level how the cell controls a number of central processes by breaking down certain proteins and not others," the academy said. "Without doubt they deserve this prize," John Mayer, professor of molecular cell biology at the University of Nottingham, told us. "Protein modification by ubiquitylation is just as important as protein phosphorylation for what goes on in the cell." Ubiquitin-mediated protein degradation governs processes as varied as cell division, DNA repair, quality control of newly produced proteins, and parts of the immune system. Problems with the ubiquitin–proteosome system are implicated in human diseases including cervical cancer and cystic fibrosis. "The reason they've got this Nobel Prize is because ubiquitin is attached to proteins in different ways not only for degradation, but also to make other things happen in the cell," Mayer added. -
A Római Köztársaság Válsága II
J U R A A Pécsi Tudományegyetem Állam- és Jogtudományi Karának tudományos lapja A tartalomból STUDIUM ANDRÁSSY GYÖRGY: A szlovák államnyelvtörvény módosítása és az emberi jogok ANDRZEJ BISZTYGA: Poland on the way to the accession to eurozone. Constitutional aspects of the issue IMRE GARACZI: Von der Weltkrise zur Tradition HADI NIKOLETT: Fogyatékosság – nyelvi jogok – jelnyelv HERGER CSABÁNÉ: Egyházi modernizáció Franciaországban 1789-től 1905-ig ANDRÁS KECSKÉS: The Legal Theory of Stakeholder Protection KOCSIS MIKLÓS – KUCSERA TAMÁS GERGELY: A magyarországi doktori képzés állapota – interdiszciplináris megközelítésben MADARÁSZNÉ IFJU BERNADETT: A családtámogatási ellátások ANDRÁS LÁSZLÓ PAP: Ethno-racial profiling and discrimination in the criminal justice system: notes on current anti-terrorist legislation and law enforcement measures PÓKECZ KOVÁCS ATTILA: A római köztársaság válsága II. (i. e. 133–44) SÁNDOR JUDIT: Biobankok: Egy sikeres fikció a tudomány szolgálatában? VOGL MÁRK: A Szlovák Köztársaság államnyelvtörvénye a 2009. évi módosítások után YA NAN ZHANG: An overview and Evaluation of Civil Judgment Enforcement System in the People’s Republic of China COLLOQUIUM MÁTÉ JULESZ: The Collectivization of the Individuals’ Right to a Healthy Environment SOMFAI BALÁZS: A Gyermek Jogairól szóló Egyezmény egyes rendelkezései a hazai jogszabályokban VÁRSZEGI ZSÓFIA MÁRIA: Szabályrendelet-alkotás Baranya vármegyében 1867 és 1886 között FORUM KUN TIBOR: Világméretű korrupció az oktatásban? PETRÉTEI KRISTÓF: Gondolatok az országgyűlési képviselők 2010. évi általános választásának időpontjáról SOMFAI BALÁZS – HARMATH GABRIELLA: „Diákok a gyermekekért” gyermekjogi program SZABÓ GÁBOR: Rawls igazságosság-elmélete és kritikái VARGA KÁROLY: Ibükosz darvai a hazai igazságszolgáltatásban ZLINSZKY JÁNOS: Észrevételek a magánjog új törvénykönyvéhez AD HOC ÁDÁM ANTAL: In memoriam Herczegh Géza CSÁSZÁR KINGA: „Symbols and Ceremonies in the European Legal History”. -
Ubiquitin-Mediated Proteolysis the Nobel Prize in Chemistry for 2004 Is
Advanced information on the Nobel Prize in Chemistry, 6 October 2004 Information Department, P.O. Box 50005, SE-104 05 Stockholm, Sweden Phone: +46 8 673 95 00, Fax: +46 8 15 56 70, E-mail: [email protected], Website: www.kva.se Ubiquitin-mediated proteolysis The Nobel Prize in Chemistry for 2004 is shared between three scientists who have made fundamental discoveries concerning how cells regulate the breakdown of intracellular proteins with extreme specificity as to target, time and space. Aaron Ciechanover, Avram Hershko and Irwin Rose together discovered ubiquitin- mediated proteolysis, a process where an enzyme system tags unwanted proteins with many molecules of the 76-amino acid residue protein ubiquitin. The tagged proteins are then transported to the proteasome, a large multisubunit protease complex, where they are degraded. Numerous cellular processes regulated by ubiquitin-mediated proteolysis include the cell cycle, DNA repair and transcription, protein quality control and the immune response. Defects in this proteolysis have a causal role in many human diseases, including a variety of cancers. Fig. 1 Ubiquitin-mediated proteolysis and its many biological functions 2 Introduction Eukaryotic cells, from yeast to human, contain some 6000 to 30000 protein-encoding genes and at least as many proteins. While much attention and research had been devoted to how proteins are synthesized, the reverse process, i.e. how proteins are degraded, long received little attention. A pioneer in this field was Schoenheimer, who in 1942 published results from isotope tracer techniques indicating that proteins in animals are continuously synthesized and degraded and therefore are in a dynamic state (Schoenheimer, 1942). -
Los Premios Nobel De Química
Los premios Nobel de Química MATERIAL RECOPILADO POR: DULCE MARÍA DE ANDRÉS CABRERIZO Los premios Nobel de Química El campo de la Química que más premios ha recibido es el de la Quí- mica Orgánica. Frederick Sanger es el único laurea- do que ganó el premio en dos oca- siones, en 1958 y 1980. Otros dos también ganaron premios Nobel en otros campos: Marie Curie (física en El Premio Nobel de Química es entregado anual- 1903, química en 1911) y Linus Carl mente por la Academia Sueca a científicos que so- bresalen por sus contribuciones en el campo de la Pauling (química en 1954, paz en Física. 1962). Seis mujeres han ganado el Es uno de los cinco premios Nobel establecidos en premio: Marie Curie, Irène Joliot- el testamento de Alfred Nobel, en 1895, y que son dados a todos aquellos individuos que realizan Curie (1935), Dorothy Crowfoot Ho- contribuciones notables en la Química, la Física, la dgkin (1964), Ada Yonath (2009) y Literatura, la Paz y la Fisiología o Medicina. Emmanuelle Charpentier y Jennifer Según el testamento de Nobel, este reconocimien- to es administrado directamente por la Fundación Doudna (2020) Nobel y concedido por un comité conformado por Ha habido ocho años en los que no cinco miembros que son elegidos por la Real Aca- demia Sueca de las Ciencias. se entregó el premio Nobel de Quí- El primer Premio Nobel de Química fue otorgado mica, en algunas ocasiones por de- en 1901 al holandés Jacobus Henricus van't Hoff. clararse desierto y en otras por la Cada destinatario recibe una medalla, un diploma y situación de guerra mundial y el exi- un premio económico que ha variado a lo largo de los años. -
Proteasome Inhibitors in Cancer Therapy: Death by Indigestion
Cell Death and Differentiation (2005) 12, 1255–1257 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Book Review Proteasome inhibitors in cancer therapy: death by indigestion M Rossi1, A Oberst2, A Emre Sayan1 and P Salomoni*,1 1 MRC, Toxicology Unit, Leicester, UK; 2 IDI-IRCCS Biochemistry Lab, c/o University of Rome Tor Vergata, Rome, Italy * Corresponding author. P Salomoni. E-mail: [email protected] Cell Death and Differentiation (2005) 12, 1255–1257. doi:10.1038/sj.cdd.4401701 Proteasome Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. By J Adams. Humana Press, Totowa, New Jersey: 2004. pp 312. ISBN: 1-58829-250-9 As Eugene Garfield said, while it is easy to recognize a good same issue containing manuscripts from scientists that have paper, it could be more difficult to recognize a bad paper. In originated in this field.7–10 fact, the results could be weak, but the conclusion could still For those of us engaged in basic research in the field be right, even though not fully supported by the data shown. of cancer and apoptosis, the hope that our work might, in Preliminary reports could also fall in this category. After some small way and at some future juncture, contribute to all, it was not a Cell but a BBRC paper – only a little BBRC of the clinical treatment of human cancers is a major motivator. three impact factor – describing a novel experimental model Proteasome Inhibitors in Cancer Therapy, edited by Julian in which to study ATP-dependent proteolysis.1 In a lysate Adams, which is part of the ‘Cancer Drug Discovery and from rabbit reticulocytes, where the proteolytic activity was not Development’ series from Humana Press, tells the happy tale due to lysosomes (pH optimum of 7.8), they separated two of one drug’s journey from concept, through development, fractions in a DEAE cellulose column, each one individually to FDA approval, and application. -
The Elie Wiesel Foundation for Humanity Nobel
THE ELIE WIESEL FOUNDATION FOR HUMANITY NOBEL LAUREATES INITIATIVE September 9, 2005 TO: Kansas State Board of Education We, Nobel Laureates, are writing in defense of science. We reject efforts by the proponents of so-called “intelligent design” to politicize scientific inquiry and urge the Kansas State Board of Education to maintain Darwinian evolution as the sole curriculum and science standard in the State of Kansas. The United States has come a long way since John T. Scopes was convicted for teaching the theory of evolution 80 years ago. We are, therefore, troubled that Darwinism was described as “dangerous dogma” at one of your hearings. We are also concerned by the Board’s recommendation of August 8, 2005 to allow standards that include greater criticism of evolution. Logically derived from confirmable evidence, evolution is understood to be the result of an unguided, unplanned process of random variation and natural selection. As the foundation of modern biology, its indispensable role has been further strengthened by the capacity to study DNA. In contrast, intelligent design is fundamentally unscientific; it cannot be tested as scientific theory because its central conclusion is based on belief in the intervention of a supernatural agent. Differences exist between scientific and spiritual world views, but there is no need to blur the distinction between the two. Nor is there need for conflict between the theory of evolution and religious faith. Science and faith are not mutually exclusive. Neither should feel threatened by the other. When it meets in October, 2005, we urge the Kansas State Board of Education to vote against the latest draft of standards, which propose including intelligent design in academic curriculum. -
Karcagi Hírmondó – 2007.05.04
KARCAGI Ezüstmise HÍRMONDÓ XX. évf. 18. szám 2007. május 4. INGYENES ÖNKORMÁNYZATI HETILAP Mesterségek Művészete Nap Didergős tavaszköszöntő Az idei, két napra szervezett tavaszköszöntő sok látniva- lóval, érdekesnek ígérkező műsorral és meglehetősen hideg idővel köszöntött be. A felvonulásos korszak el- múltával május elseje a leg- több helyen művészeti, kul- turális vagy sport programok alkalma lett, nem mellőzve természetesen a szűkebb kör- A karcagi Szent István temp- pá. „Aki ezt a hivatást választ- ben szervezett összejövetele- lomban 2007. április 30-án ja – emlékezett a plébános úr ket és a birkafőzést sem. Ma- emlékeztek Galsi János plé- –, annak az életében valahol a radt persze a seregszemle jel- bános úr pappá szentelésé- papszentelés a legnagyobb ese- legből is, hiszen a két napon nek 25. évfordulójára. A zsú- mény, hiszen öt éven keresz- ifjú művészek, táncosok, és folásig megtelt templom- tül erre a napra készül. És ar- különféle kismesterségek je- ban János atya mutatta be a ra, hogy igyekezzen teljesíteni lesei mutatkozhattak be. szentmisét, majd Mészáros mindent, amit vállalt. A Jóis- Hétfőn délelőtt Csipkecso- Ferenc káplán szólt az össze- ten szolgálatában dolgozni, és dák címmel huszonkét csip- gyűltekhez. abban meg is maradni.” A fi- keverő valóban csodás mun- Galsi János atya, aki tizen- atal pap még abban az időben káiból nyílt kiállítás a Déry- öt éve szolgál városunkban, kezdte a szolgálatot, mikor ál- né Művelődési Központban. Törökszentmiklóson született lami szervek még élénken ér- Délután ugyanitt került sor 1958. február 5-én. Édesap- deklődtek különösen a fiatal, a testvérvárosaink fiatalsága ja gazdálkodó, majd Tsz-tag, energikus káplánok tevékeny- részére meghirdetett maszk- Folytatás a 4. oldalon édesanyja harangozó volt, hat sége iránt, s könnyű volt össze- gyermekük született. -
Steven J. Cohen, Md
STEVEN J. COHEN, MD Background Oncology Cornell University Director, Rosenfeld Cancer Center and Cancer Service Line Ithaca, NY Chief, Medical Oncology and Hematology Division (BA, Psychology, 1988-1992) Vice-Chair, Department of Medical Oncology Professor of Medical Oncology, Thomas Jefferson University, Stony Brook University School of Medicine Sidney Kimmel Cancer Center Stony Brook, NY (MD, 1992-1996) Steven J. Cohen, MD earned his Bachelor’s degree in Psychology Temple University Hospital in 1992 from Cornell Philadelphia, PA University. In 1996, he earned (Resident, Internal Medicine, 1996-1999) his medical degree from the State University of New York at Fox Chase Cancer Center Stony Brook. Dr. Cohen Temple University Hospital completed his residency in Philadelphia, PA Internal Medicine at Temple (Fellow, Medical Oncology and Hematology, 1999-2001) University Hospital in 1999. He (Chief Fellow, Medical Oncology and Hematology, 2001- completed his fellowship in 2002) Medical Oncology and (Program Director, Hematology/Oncology Fellowship, Hematology in 2002 at Fox 2009-2016) Chase Cancer Center, and also served as Chief Fellow from 2001 to 2002. Fox Chase Cancer Center Philadelphia, PA Dr. Cohen specializes in the care and treatment of GI cancers. He is a member of the American Society of Clinical (Assistant Member, Division of Medical Science, 2002- Oncology, where he has served on the Scientific Program 2004) Committee for Colorectal Cancer and chaired the Test (Attending Physician, Department of Medical Oncology, Development Committee. He is an active member of the GI 2002-2004) Committee of the Eastern Cooperative Oncology Group (Assistant Professor, Divisions of Medical and Population where he has chaired the Colorectal Cancer Subcommittee. -
The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell Division Cycle*
Cell Death and Differentiation (2005) 12, 1191–1197 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Review: Nobel Lecture The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle* A Hershko*,1 further molecular mechanisms that regulate the expression of specific genes. Owing to the intensive research activity on 1 The B. Rappaport Faculty of Medicine and the Rappaport Institute for protein synthesis, little attention was paid at that time to the Research in the Medical Sciences, Technion-Israel Institute of Technology, fact that many proteins are rapidly degraded to amino acids. Haifa, Israel This dynamic turnover of cellular proteins had been previously * Corresponding author: A Hershko, Unit of Biochemistry, the B. Rappaport known by the pioneering work of Schoenheimer and co- Faculty of Medicine and the Rappaport Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, 1 Efron Street, P.O. Box workers, who were among the first to introduce the use of 9649, Haifa 31096, Israel. Fax: 9724 853 5773; isotopically labeled compounds to biological studies. They 15 E-mail: [email protected] administered N-labeled L-leucine to adult rats, and the distribution of the isotope in body tissues and in excreta was Received 18.5.05; accepted 18.5.05 examined. It was observed that less than one-third of the Edited by G Melino isotope was excreted in the urine, and most of it was incorporated into tissue proteins.1 Since the weight of the Abstract animals did not change during the experiment, it could be assumed that the mass and composition of body proteins also Owing to the intensive research activity on protein synthesis, did not change. -
Early Work on the Ubiquitin Proteasome System, an Interview with Irwin Rose
Cell Death and Differentiation (2005) 12, 1162–1166 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Interview Early work on the ubiquitin proteasome system, an interview with Irwin Rose I Rose*,1 Irwin Rose was one of the first scientists working on UPS mechanisms. In particular, his early work was dedicated to the 1 Department of Physiology and Biophysics, College of Medicine, University of biochemistry and the role of nonlysosomal protein degra- California, Irvine, CA 92697, USA dation. But how did it all begin? What triggered his scientific * Corresponding author: I Rose, Department of Physiology and Biophysics, interest in this field from his previous work? Now a large College of Medicine, University of California, Irvine, CA 92697, USA. family of related proteins exist, with interesting therapeutical E-mail: [email protected] potential. Here, Cell Death and Differentiation asks Irwin Cell Death and Differentiation (2005) 12, 1162–1166. Rose about the early work on enzymology. This interview doi:10.1038/sj.cdd.4401700 was obtained, thanks to the kind help of the Nobel Foundation in Stockholm, http://nobelprize.org (rThe Nobel Founda- tion 2004). CDD: How did you Move from your Early Family Life into your Scientific Interest? We left my birthplace, Brooklyn, New York in 1939 when I was 13. I enjoyed the ethnic variety and the interesting students in my public school, P.S. 134. The kids in my neighborhood were only competitive in games although unfriendly gangs tended to define the limits of our neighborhood. The major extracurricular activities that I can remember were a Victory Garden on school grounds, our contribution to the war effort, and a favorite sport, handball, played between the walls of our apartment house. -
Programme 70Th Lindau Nobel Laureate Meeting 27 June - 2 July 2021
70 Programme 70th Lindau Nobel Laureate Meeting 27 June - 2 July 2021 Sessions Speakers Access Background Scientific sessions, Nobel Laureates, Clear guidance Everything else social functions, young scientists, to all viewing there is to know partner events, invited experts, and participation for a successful networking breaks moderators options meeting 2 Welcome Two months ago, everything was well on course to celebrate And yet: this interdisciplinary our 70th anniversary with you, in Lindau. anniversary meeting will feature But with the safety and health of all our participants being the most rich and versatile programme ever. of paramount importance, we were left with only one choice: It will provide plenty of opportunity to educate, inspire, go online. connect – and to celebrate! Join us. 4 PARTICIPATING LAUREATES 4 PARTICIPATING LAUREATES 5 Henry A. Joachim Donna George P. Hartmut Michael M. Adam Hiroshi Kissinger Frank Strickland Smith Michel Rosbash Riess Amano Jeffrey A. Peter Richard R. James P. Randy W. Brian K. Barry C. Dean Agre Schrock Allison Schekman Kobilka Barish John L. Harvey J. Robert H. J. Michael Martin J. Hall Alter Grubbs Kosterlitz Evans F. Duncan David J. Ben L. Edmond H. Carlo Brian P. Kailash Elizabeth Haldane Gross Feringa Fischer Rubbia Schmidt Satyarthi Blackburn Robert B. Reinhard Aaron Walter Barry J. Harald Takaaki Laughlin Genzel Ciechanover Gilbert Marshall zur Hausen Kajita Christiane Serge Steven Françoise Didier Martin Nüsslein- Haroche Chu Barré-Sinoussi Queloz Chalfie Volhard Anthony J. Gregg L. Robert J. Saul Klaus William G. Leggett Semenza Lefkowitz Perlmutter von Klitzing Kaelin Jr. Stefan W. Thomas C. Emmanuelle Kurt Ada Konstantin S. -
Declaration Accepted by the Plenary Meeting of the Nobel Laureates at the PETRA IV Meeting on 19 June 2008 and Released by the Elie Wiesel Foundation
Declaration accepted by the Plenary Meeting of the Nobel Laureates at the PETRA IV Meeting on 19 June 2008 and released by the Elie Wiesel Foundation We, undersigned Nobel Laureates, commend the remarkable progress made in creating the SESAME Synchrotron Light Source. It will provide a major center for scientific research, with ownership shared by many nations of the Middle East. Thereby, SESAME, as well as producing educational and economic benefits, will serve as a beacon, demonstrating how shared scientific initiatives can help light the way towards peace. We urge all friends of science and peace to lend their encouragement and support to this exemplary project. Signed by 44 Laureates (see list below) Kenneth J. Arrow Economics 1972 Günter Blobel Physiology or Medicine 1999 Paul D. Boyer Chemistry 1997 Aaron Ciechanover Chemistry 2004 Claude Cohen-Tannoudji Physics 1997 Elias James Corey Chemistry 1990 Paul J. Crutzen Chemistry 1995 Frederik W. de Klerk Peace 1993 Johann Deisenhofer Chemistry 1988 Sir Martin J. Evans Physiology or Medicine 2007 John B. Fenn Chemistry 2002 Edmond H. Fischer Physiology or Medicine 1992 Jerome I. Friedman Physics 1990 Donald A. Glaser Physics 1960 Clive W.J. Granger Economics 2003 Paul Greengard Physiology or Medicine 2000 David J. Gross Physics 2004 Roger Guillemin Physiology or Medicine 1977 Dudley R. Herschbach Chemistry 1986 Avram Hershko Chemistry 2004 Roald Hoffmann Chemistry 1981 John Hume Peace 1998 Eric R. Kandel Physiology or Medicine 2000 Roger D. Kornberg Chemistry 2006 Finn E. Kydland Economics 2004 Yuan T. Lee Chemistry 1986 Jean-Marie Lehn Chemistry 1987 Rudolph A. Marcus Chemistry 1992 Craig C.